Logo

Vol. 131, No. 3

March 28, 2021
On this page
Inflammatory bowel disease is associated with higher seroprevalence rates of antibodies against SARS-CoV-2
Michał Łodyga, Katarzyna Maciejewska, Piotr Eder, Katarzyna Waszak, Kamila Stawczyk-Eder, Michał Michalak, Agnieszka Dobrowolska, Maria Wiśniewska-Jarosińska, Anita Gąsiorowska, Małgorzata Cicha, Waldemar Wierzba, Grażyna Rydzewska
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 226–232; DOI: 10.20452/pamw.15796
Endoscopic treatment of rectal neuroendocrine tumors in a 13-year retrospective single-center study: are we following the guidelines?
Krzysztof Dąbkowski, Natalia Rusiniak-Rossińska, Karolina Michalska, Andrzej Białek, Elżbieta Urasińska, Beata Kos-Kudła, Teresa Starzyńska
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 241–248; DOI: 10.20452/pamw.15823
Epicardial, pericardial fat and glucagon-like peptide-1 and -2 receptors expression in stable patients with multivessel coronary artery disease: an association with the renin-angiotensin-aldosterone system
Maciej Haberka, Aleksander Siniarski, Grzegorz Gajos, Grzegorz Machnik, Adam Kowalówka, Marek Deja, Bogusław Okopień, Zbigniew Gąsior
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 233–240; DOI: 10.20452/pamw.15797
Determination of the optimal on-treatment diastolic blood pressure range using automated office measurements in patients without cardiovascular disease
Piotr Sobieraj, Jacek Lewandowski, Maciej Siński
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 249–256; DOI: 10.20452/pamw.15789
T helper 17 cell responses induce cardiac hypertrophy and remodeling in essential hypertension
Liangjie Xu, Guanghua Chen, Yi Liang, Cuicui Zhou, Fen Zhang, Tingpan Fan, Xinxin Chen, Hong Zhou, Wei Yuan
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 257–265; DOI: 10.20452/pamw.15811
Subclinical hypothyroidism in pregnancy: controversies on diagnosis and treatment
Małgorzata Gietka-Czernel, Piotr Glinicki
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 266–275; DOI: 10.20452/pamw.15626
A comprehensive review on posttreatment surveillance in colorectal patients
Piotr T. Wysocki
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 276–287; DOI: 10.20452/pamw.15442
An innovative method for the management of complicated chronic pancreatitis
Mateusz Jagielski, Łukasz Bereziak, Jacek Piątkowski, Marek Jackowski
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 288–289; DOI: 10.20452/pamw.15808
Strangulated internal abdominal hernia caused by horse riding
Krzysztof Kaliszewski, Dominika Szwed, Anna Śliwa, Jerzy Rudnicki
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 290–291; DOI: 10.20452/pamw.15805
One patient, two rare diseases: coexistence of epidermodysplasia verruciformis and Merkel cell carcinoma
Joanna Sułowicz, Dorota Wielowieyska-Szybińska, Anna Wojas-Pelc
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 295–296; DOI: 10.20452/pamw.15809
Rheolytic thrombectomy with local thrombolysis in a patient with COVID-19 pneumonia and acute pulmonary embolism
Marcin Krakowian, Michał Machowski, Michał Potępa, Ewelina Zawadzka-Bartczak, Piotr Pruszczyk, Marek Roik
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 292–294; DOI: 10.20452/pamw.15807
Amyloidosis, extramedullary plasmacytoma, and light chain deposition disease: impressive results of daratumumab therapy
Magdalena Wiklik-Dziadek, Joanna Jaworek-Troć, Artur Jurczyszyn
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 297–298; DOI: 10.20452/pamw.15806
Polymorphisms of genes coding for telomerase reverse transcriptase and telomerase RNA component and the need for target lesion revascularization after percutaneous coronary intervention
Kamil Bujak, Mateusz Lejawa, Martyna Fronczek, Andrzej Lekston, Mariusz Gąsior, Tadeusz Osadnik
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 299–301; DOI: 10.20452/pamw.15810
High-resolution computed tomography over chest radiography: how the pandemic changed our evaluation policy of potential kidney transplant recipients
Jolanta Małyszko, Tadeusz Grochowiecki, Michał Macech, Urszula Ołdakowska-Jedynak, Ewa Wojtaszek, Sławomir Nazarewski
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 302–305; DOI: 10.20452/pamw.15850
Potential role of plant microRNAs in the pathogenesis of autosomal dominant polycystic kidney disease: an in silico study
Mariusz Niemczyk, Arkadiusz Gładki, Agnieszka Gromadka, Piotr Zielenkiewicz, Leszek Pączek
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 306–308; DOI: 10.20452/pamw.15804
Impact of endosonography‑guided fine‑needle aspiration and biopsy on the management of patients with suspected pancreatic neuroendocrine tumors
Michał Żorniak, Ksenia Janas, Michał Wójcik, Piotr Dziadkiewicz, Mateusz Chapuła, Kamil Barański
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 309–312; DOI: 10.20452/pamw.15802
Hypoglycemia as a medication-related harm identified in patients admitted to geriatric wards
Jan Brož, Klára Brožová
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 313–314; DOI: 10.20452/pamw.15905
Hypoglycemia as a medication-related harm identified in patients admitted to geriatric wards. Author's reply
Barbara Bień
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 313–314; DOI: 10.20452/pamw.15906
The obesity pandemic among patients with coronary artery disease: do we have enough to tackle its progression? Authors' reply
Piotr Jankowski, Paweł Kozieł, Andrzej Pająk
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 315–315; DOI: 10.20452/pamw.15908
The obesity pandemic among patients with coronary artery disease: do we have enough to tackle its progression?
Dimitrios Patoulias, Fotios Siskos, Aristi Boulmpou, Christodoulos Papadopoulos, Michael Doumas
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 315–316; DOI: 10.20452/pamw.15907
Erythropoietin: a story of a discovery with Polish contribution
Ryszard W. Gryglewski, Andrzej Deptała, Maria Podolak-Dawidziak, Jadwiga Dwilewicz-Trojaczek, Jan Walewski, Artur Jurczyszyn
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 317–319; DOI: 10.20452/pamw.15909
Low risk of severe COVID‑19 in patients with inflammatory bowel disease: keep calm and take stock
Mariangela Allocca, Vincenzo Craviotto
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 222–223; DOI: 10.20452/pamw.15903
Can epicardial fat glucagon-like peptide-1 receptor open up to the cardiovascular benefits of glucagon-like peptide-1 analogues?
Gianluca Iacobellis
Pol Arch Intern Med. 2021, Vol. 131, No. 3: 224–225; DOI: 10.20452/pamw.15904